Tirzepatide was developed by Eli Lilly and received FDA approval in May 2022 under the name Mounjaro as a Type 2 diabetes treatment
Sun H, Shu J, Tang J, et al
Similar content being viewed by others Background Glucagon-like peptide-1 (GLP-1) is a peptide hormone known for its role in regulating glucose homeostasis and satiety
10.1111/pcmr.12941 Pigment Cell Melanoma Res
It also plays a supporting role in fat metabolism and may help lower cholesterol over time
In terms of metabolic regulation, GLP-1RAs exert their effects through various pathways, including increasing insulin sensitivity, maintaining glucose homeostasis, promoting weight control, and improving lipid metabolism